Synthetic Human Secretin in Children With Autism
NCT00036244 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2005-08-05
Summary
The purpose of the study is to determine whether multiple doses of secretin are safe and effective in the treatment of children with autism.
Conditions
Interventions
- DRUG
-
RG1068 (Synthetic Human Secretin)
Sponsors & Collaborators
-
Repligen Corporation
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 32 Months
- Max Age
- 59 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-04-30
- Completion
- 2004-01-31
Countries
- United States
Study Locations
More Related Trials
-
A Study of RO4917523 in Pediatric Patients With Fragile X Syndrome
NCT01750957 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Extension of GTX-102 in Angelman Syndrome
NCT06415344 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
SynapDx Autism Gene Expression Analysis Study
NCT01716845 ·Status: COMPLETED
-
Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS
NCT03802799 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3
-
ANAVEX2-73 Study in Patients With Rett Syndrome
NCT03941444 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome
NCT07228403 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX)
NCT03614663 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
NCT02715115 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of Metformin in Individuals With Fragile X Syndrome
NCT03479476 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of ANAVEX2-73 in Patients With Rett Syndrome
NCT03758924 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial
NCT04881825 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study to Assess Safety and Efficacy of Fingolimod in Children With Rett Syndrome
NCT02061137 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU
NCT03694353 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of AFQ056 in Adolescent Patients With Fragile X Syndrome
NCT01357239 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety Study of NNZ-2566 in Patients With Rett Syndrome
NCT01703533 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Tolerability of a Single Dose of STX107 in Adults With Fragile X Syndrome
NCT01325740 ·Status: SUSPENDED ·Phase: PHASE2
-
Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS)
NCT06617429 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study of Acamprosate in Fragile x Syndrome
NCT01911455 ·Status: COMPLETED ·Phase: PHASE1
-
To Study the Efficacy & Safety of Oral NA-921 (Bionetide) in Girls and Women with Rett Syndrome
NCT06849973 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria
NCT05270837 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms
NCT02790034 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
NCT01894958 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of Metformin in Individuals With Fragile X Syndrome (Met)
NCT03862950 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
NCT00634660 ·Status: COMPLETED ·Phase: PHASE1
-
An Exploratory Clinical Trial of VGN-R08b in Patients With Type II Gaucher Disease
NCT06272149 ·Status: RECRUITING ·Phase: EARLY_PHASE1